Heart catheter cable and connector

Ultraminiature catheter cables that are stiff enough for intravenous insertion yet flexible at the tip, sterilizable, and economical are fabricated entirely from commercially available parts. Assembly includes air passageway for reference pressures and coaxial cable for transmission of signals from the tip of catheter

Development of improved adhesives for use at cryogenic temperatures to minus423 deg F Final summary report, 11 Jul. 1963 - 31 Aug. 1965

Improved polyurethane and epoxy resins for use as adhesives at cryogenic temperature

Evaluation of the cardiovascular system during various circulatory stresses Progress report, 1 Sep. 1968 - 1 May 1969

Cardiac response to chemotherapy after myocardial infraction and diagnostic methods of heart disease in man and animal

Cross-Border Competition in the European Union: Public Procurement and the European Defence Equipment Market

This Article first considers public procurement and competition, highlighting unique issues applicable to a competitive defense equipment market, the need for targeted guidance on defense procurement, and the application of Article 296. After setting the issue in context, consideration will be made of the evolution and the 2004 modernization of public procurement policy. Discussion thereafter will focus on the establishment of a competitive defense equipment market, Article 296, and the Commission’s 2006 Interpretative Communication on its application. The main points of the Defence Package will be identified. A commentary with respect to the Treaty of Lisbon is also included. The conclusion will address whether pending procurement initiatives are likely to enhance cross-border competition, particularly with regard to the defense sector

Phenolphthalein-containing laxative use in relation to adenomatous colorectal polyps in three studies.

Phenolphthalein, the active ingredient in many laxatives, was recently found to be a carcinogen in animal models. Human data suggest a laxative-colon cancer association, but few data specifically address the effects of phenolthalein-containing laxatives. We examined use of phenolphtalein-containing laxatives in relation to occurrence of adenomatous colorectal polyps in data from three case-control studies. The study conducted in Los Angeles, California (1991-1993), and the two studies conducted in North Carolina (1988-1990 and 1992-1995) altogether included 866 cases and 1,066 controls. The prevalence of using phenolphthalein-containing laxatives at least once a week in the recent past, however, was less than 5% among these subjects. The multivariate-adjusted odds ratios associated with recent use of phenolphthalein-containing laxatives once a week or more were 1.8 -95% confidence interval (CI), 0.5-6.2] in Los Angeles, 1.0 (CI, 0.4-2.2) in North Carolina (1988-1990), and 1.1 (CI, 0.2-5.7) in North Carolina (1992-1995). For use of other types of laxatives, the corresponding odds ratios were 1.3 (CI, 0.9-1.9) in Los Angeles, 1.0 (CI, 0.5-1.7) in North Carolina (1988-1990), and 0.9 (CI, 0.4-1.8) in North Carolina (1992-1995). Although the low prevalence of frequent use made for relatively wide confidence intervals, overall these data suggest that use of phenolphthalein-containing laxatives does not increase risk of adenomatous colorectal polyps

PUBLICLY-SUPPORTED SINGLE SEX SCHOOLS AND POLICY ISSUES

Panel II: Constitutional, Statutory, and Policy Issues Raised by All-Female Public Educatio

Primary pneumaturia

Click on the link to view